Biohaven’s data delay degrades stock price
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Category: Medicine
.jpg)
STAT+: Pharmalittle: We’re reading about CVS and Humira biosimilars, Schumer’s broken insulin promise, and more
Top of the morning to you, and a fine one it is. Clear blue skies…
STAT+: Intra-Cellular reports positive results in depression study aimed at expanding use of antispsychotic medicine
Intra-Cellular Therapies reported positive results Tuesday from a late-stage clinical trial seeking to expand the…
STAT+: Chuck Schumer’s broken promise on affordable insulin
WASHINGTON — In February 2022, Senate Majority Leader Chuck Schumer stood alongside constituents in Buffalo,…
STAT+: A new PIPE lawsuit challenges the fairness of sharing confidential, stock-moving information
The fairness of PIPEs, particularly the preferential sharing of confidential, stock-moving information, is now a…
STAT+: Grocers are pushing legislation they claim would enhance food safety. Advocates say it would gut FDA rules
WASHINGTON – In the last decade, Americans have been sickened by salmonella from cucumbers, listeria…
Opinion: Autism doesn’t discriminate. Autism research shouldn’t either
The face of autism was once predominantly white. No longer. The Centers for Disease Control…
STAT+: Thanks to CVS, a biosimilar version of AbbVie’s Humira is grabbing huge market share
The number of new prescriptions written for biosimilar versions of the Humira rheumatoid arthritis treatment,…
STAT+: Cerebral to pay $7 million fine and limit health data use for ads under federal order
Telehealth company Cerebral will limit the consumer health data it uses for advertising purposes under…
Medicare expects a big spike in spending on Leqembi
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money…
A two-decade bet on Seagen pays off
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about a J&J cough syrup, a Pfizer and Moderna patent suit, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Ultragenyx reports early success with Angelman syndrome drug, backing up 2022 acquisition
Ultragenyx has found early success with its experimental treatment for the rare disease Angelman syndrome,…
STAT+: Can investing in infectious disease pay off? Vir Biotechnology’s tightrope walk shows it’s a struggle
Nearly a decade ago, venture capitalist Bob Nelsen called industry veteran Vicki Sato to pitch…
STAT+: Mass General Brigham is ready to move on without Dana-Farber, CEO says
CHICAGO — The split between Dana-Farber Cancer Institute and Mass General Brigham has been messy….
Opinion: ADHD is often overlooked in females. They need help, too
Boys aren’t the only people who develop attention-deficit/hyperactivity disorder (ADHD). It also affects girls and…
Opinion: Hospitals that make profits should pay taxes
As diligent taxpayers breathe a sigh of relief that the hassle of filing their tax…
.jpg)
Opinion: Readers respond to OTC antidepressants, personalized medicine, restoring trust in public health, and more
STAT publishes selected Letters to the Editor received in response to First Opinion essays to…
STAT+: Colorado lawmakers revise effort to exempt rare disease drugs from state cost caps
In response to controversy, a group of Colorado lawmakers is abandoning a bill that would…
Opinion: H5N1 bird flu in U.S. cattle: A wake-up call to action
The recent detection of H5N1 bird flu in U.S. cattle, coupled with reports of a…
What about the company Vertex didn’t buy?
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about AstraZeneca CEO pay, alternatives to WuXi and more
And so, another working week will soon draw to a close. Not a moment too…
European regulators find no evidence of link between new obesity medicines and suicidal thoughts
LONDON — Following a nine-month investigation, European regulators said Friday they have found no evidence…
Opinion: Needed for reproductive justice and autonomy: women in design
Powerful groups of mostly men are making major decisions about biology and bodies they know…
What the noses of mice can tell us about the inheritance of trauma
In the final year of World War II, Nazi troops starved the Netherlands in a…
Opinion: Congress: Protect patients and enact the Nuclear Medicine Clarification Act
If a preventable error that might cause harm occurs during medical care, should there be…
High physician empathy could offer patients with lower back pain lasting benefits, study shows
Amid the many demands of practicing medicine, doctors can have less time and energy for…
STAT+: FTC cracks down on telehealth addiction service Monument for sharing health data
On Thursday, the Federal Trade Commission took action against alcohol addiction telehealth company Monument, affirming…
Listen: Vertex’s big deal, biotech’s red numbers, & an industry history lesson
How would you spend $13 billion in cash? Is biotech stale? And remember Dendreon? We…
STAT+: The inside story of Enhertu’s pan-tumor approval
This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers…
Gas prices are hurting biotech
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about drug shortages, Medicare spending on an Alzheimer’s drug, and more
Hello, everyone, and how are you today? We are doing just fine, thank you, despite…
STAT+: European Parliament votes in favor of updated pharma legislation, prompting mixed reactions
The European Parliament has voted overwhelmingly to adopt legislation that is supposed to transform the…
STAT+: When a cancer drug fails, oncologists often fly blind. A precision technique might light the way
It seemed as if Logan Jenner had the best possible chance for a cure. Diagnosed…
Opinion: To rebuild trust in public health: Better communication, fewer mandates, and small wins
It’s no surprise in today’s corrosive political environment that trust in government is near an…
$10 billion long Covid ‘moonshot’ is being floated by Bernie Sanders
WASHINGTON — Bernie Sanders is pushing for a long Covid “moonshot.” He released a draft…
STAT+: Telehealth providers can drive antibiotic overuse — or choose to combat it
Ho Anh had just started working at Lemonaid Health when he was caught up in…
STAT+: Medicare expects to spend $3.5 billion on new Alzheimer’s drug in 2025
Medicare for the first time has estimated that a new Alzheimer’s treatment could cost the…
STAT+: Drug shortages reached a record high as 2023 drew to a close
The number of ongoing and active drug shortages in the U.S. stood at 323 during…
STAT+: Regeneron accused by Justice Department of manipulating Medicare pricing
The U.S. Department of Justice filed a lawsuit accusing Regeneron Pharmaceuticals of manipulating Medicare pricing…
STAT+: Vertex to buy Alpine Immune Sciences for $4.9 billion
Vertex Pharmaceuticals will buy Alpine Immune Sciences, a maker of protein-based medicines that harness the…
STAT+: BIO’s top lobbyist exits, signaling reorganization
WASHINGTON — The biotech industry’s largest trade group has parted ways with its top lobbyist,…
STAT+: Pharmalittle: We’re reading about a 486% drug price hike, AstraZeneca CEO pay, and more
Hello, everyone, and how are you today? We are doing just fine, thank you, especially…
AskBio CSO steps down, has new project in stealth mode
Want to stay on top of the science and politics driving biotech today? Sign up to get…
Opinion: Mental health screening tools for kids are 30 years out of date
Suicide is the second leading cause of death among children aged 10 to 14 in…
STAT+: Did you say 486%? Why one company thinks such a price hike for its drug is justified
In an era when huge price hikes for prescription drugs are almost guaranteed to draw…
STAT+: Cancer vaccines gain momentum, after years of disappointing results
SAN DIEGO — Cancer vaccines have traveled a potholed road over the last decade. But…
NCI director expresses optimism about next era of cancer research, despite shrinking budget and brain drain
SAN DIEGO — Kimryn Rathmell, director of the National Cancer Institute, gestured toward the screen…
Opinion: Cancer is a killer. So is the fear of it
The widespread attention to the recent revelations of cancer diagnoses by Princess Catherine, actress Olivia…
Philips, maker of millions of defective sleep apnea machines, ordered to overhaul manufacturing
WASHINGTON — The company responsible for a global recall of sleep apnea machines will be barred…